Related Experiment Video
Updated: Sep 17, 2025
07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.2K
Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy
Song Li1, Jana Zarubova2, Mohammad Hasani-Sadrabadi2
1UCLA.
Research Square
|June 30, 2025
Summary
Pluripotent stem cell-derived extracellular vesicles (EVs) show superior immune tolerance capabilities compared to mesenchymal stem cell EVs. These engineered EVs offer a promising platform for next-generation immunotherapies and cell-based treatments.
Area of Science:
- Immunology
- Stem Cell Biology
- Extracellular Vesicles
Background:
- Immune tolerance in embryos is not fully understood.
- Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are used for immunomodulation.
- Pluripotent stem cells (PSCs) also secrete EVs.
Purpose of the Study:
- To compare the immunomodulatory potential of PSC-derived EVs versus MSC-derived EVs.
- To characterize the molecular composition of PSC EVs.
- To evaluate the therapeutic efficacy of PSC EVs in an autoimmune disease model.
Main Methods:
- Comparative analysis of PSC EVs and MSC EVs for immune suppression and T-cell modulation.
- Nuclear magnetic resonance (NMR), proteomic profiling, and microRNA sequencing to characterize EV molecular fingerprints.
- Assessment of iPSC EV therapeutic potential in a type 1 diabetes mouse model, including delivery via biomaterial scaffolds.
Main Results:
- PSC EVs demonstrated superior suppression of pro-inflammatory cytokines and enhanced regulatory T-cell (Treg) induction compared to MSC EVs.
- PSC EVs possess unique proteins (ROR1, CD133) and microRNAs (miR-302 family) not found in MSC EVs.
- iPSC EV treatment significantly improved diabetes-free survival, increased Treg populations, and preserved pancreatic beta-cell function in vivo.
Conclusions:
- PSC EVs exhibit potent immunomodulatory properties, outperforming MSC EVs.
- PSC EVs represent a scalable and consistent source for advanced immunotherapies.
- PSC EVs hold significant promise for treating autoimmune diseases and enhancing cell-based therapies through immune tolerance induction.
More Related Videos
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
1.9K
12:02Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
Published on: November 11, 2021
4.3K
Related Concept Videos
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:19Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
01:05Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K